Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-24

FDA Approved: LIRAGLUTIDE — Original Application (Orbicular Pharmaceutical Technologies Private Limited)

View source ↗

Summary

FDA approved the original application for a generic liraglutide product from Orbicular Pharmaceutical Technologies Private Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

ORIG AP for LIRAGLUTIDE (LIRAGLUTIDE)